Anodyne Nanotech Advances Sarcopenia Treatment with New Muscle Therapy
June 9, 2025
Anodyne Nanotech, a clinical-stage biotech company, announced new preclinical data demonstrating that administration of ANN-102 – an APJ receptor agonist via its proprietary HeroPatch microneedle